CP-461 for the Treatment of Crohn's Disease

Clinical trial NCT00042055 · COMPLETED

Trial details

NCT number: NCT00042055
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.